The US silent heart attack market is estimated to grow modestly at a CAGR of around 6.4% during the forecast period. The US contributes significantly to the growth of the silent heart attack treatment market in North America. The US has a high incidence and prevalence rate of heart diseases due to a sedentary lifestyle, excessive consumption of alcohol, consumption of junk food, and a huge number of diabetic and obese patients. According to the Center for Disease Control and Prevention (CDC), every year, around 0.8 million Americans have a heart attack. In the US, every 40 seconds, someone has a heart attack and a 1 in 5 heart attack that occurs is silent. As per the Institute for Health Metrics and Evaluation, the incidence of CVD is increasing continuously in the country.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/us-silent-heart-attack-market

The US silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). ECG is the most used technology to diagnose a silent heart attack. ECG provides insights about heart rate, indicates if there is an enlargement of the heart due to high blood pressure (hypertension) or evidence of a previous heart attack.


A Full Report of US Silent heart attack Market is Available at: https://www.omrglobal.com/industry-reports/us-silent-heart-attack-market

The companies which are contributing to the growth of the US silent heart attack market include Abbott Laboratories Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bayer AG, and Novartis AG. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.


The market study of the US silent heart attack market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.


US Silent heart attack Market Segmentation
US Silent Heart Attack Market by Diagnosis
• Electrocardiography (ECG)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)


US Silent Heart Attack Market by Treatment
• Medication
• Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant

US Silent Heart Attack Market by End-Users
• Hospital & Clinics
• Ambulatory Surgical Centers


US Silent heart attack Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• Astellas Pharma Inc.
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim GmbH
• Boston Scientific Corp.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Medtronic PLC
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Siemens AG
• Takeda Pharmaceutical Co. Ltd.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/fungicide-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404